Discussing cancer value from three continents, Dr. Lowell Schnipper (representing ASCO) in the U.S., Dr. Ahmed Elzawawy, ICEDOC, Int. Campaign for Establishment and Development of Oncology Centres, Professor of Medicine Dr. David Kerr, CMO Oxford Cancer Solutions in the UK. Does high cost cancer care give cancer patients the best chance of survival? We tend to equate expense with effectiveness. The numbers don't support that. Some of the most expensive and commonly prescribed medical tests and treatments are not evidence-based and offer very little proven value to the patient. This is a global issue that needs to be addressed as more and more people are being diagnosed with cancer, and surviving the disease. Listen live M-T 2:00 pm ET www.W4CS.com, Joni at www.JoniAldrich.com